A. Moghaddam, F. Sheybani, Atefeh Behboudifar, H. Naderi, N. Morovatdar, B. Dadpour, Nasrin Khosravi, J. Rashid, M. Hoseini
{"title":"伊朗住院成年患者对乙酰氨基酚的超剂量治疗","authors":"A. Moghaddam, F. Sheybani, Atefeh Behboudifar, H. Naderi, N. Morovatdar, B. Dadpour, Nasrin Khosravi, J. Rashid, M. Hoseini","doi":"10.22034/IJPS.2018.85076.1429","DOIUrl":null,"url":null,"abstract":"Background: Acetaminophen is the most commonly used analgesic and fever-lowering agent that is prescribed in a high percentage of patients. Due to the high prevalence of the administration of this drug, even a small percentage of errors in prescription can be significant and have important implications. The aim of the present study was to determine the frequency of supratherapeutic dosing of acetaminophen among hospitalized adult patients and its association with clinical outcomes. Methods and Materials: We conducted a retrospective, cross sectional study of all hospitalized adult patients in a teaching hospital affiliated to Mashhad University of Medical Sciences, Mashhad, Iran. Results: During the three-month study period, 4,781 (24.83%) out of 19,252 hospitalized cases received acetaminophen. Of those who received acetaminophen, 264 (5.5%) cases received a supratherapeutic dose at least once. Of 611 incidences of supratherapeutic dosing, 99.1% occurred in surgical wards and surgical intensive care units (ICUs), and 98.8% was associated with receiving parenteral formulations of acetaminophen. Multivariate analysis indicated supratherapeutic dosing of acetaminophen was significantly associated with multiple factors including female gender, older age, and longer length of hospital stays. Conclusion: All things considered, the percentage of hospitalized adult patients who received any dose of acetaminophen at our center was considerably less than other countries. Despite this, the frequency of instances of supratherapeutic dosing of this medication was significant (i.e. 17.6 days per 1,000 patient-days). Considering recent reports concerning the risk of hepatotoxicity associated with the repeated use of supratherapeutic doses of acetaminophen, continuous monitoring of acetaminophen utilization in order to prevent these instances is needed. Furthermore, based on the low percentage of patients who receive acetaminophen at our center, conducting research to study the pattern of prescription of analgesics and antipyretics in our center and its association with clinical outcome is logical.","PeriodicalId":14582,"journal":{"name":"Iranian Journal of Pharmaceutical Sciences","volume":"15 1","pages":"83-90"},"PeriodicalIF":0.0000,"publicationDate":"2019-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Supratherapeutic Dosing of Acetaminophen in Iranian Hospitalized Adult Patients\",\"authors\":\"A. Moghaddam, F. Sheybani, Atefeh Behboudifar, H. Naderi, N. Morovatdar, B. Dadpour, Nasrin Khosravi, J. Rashid, M. Hoseini\",\"doi\":\"10.22034/IJPS.2018.85076.1429\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Acetaminophen is the most commonly used analgesic and fever-lowering agent that is prescribed in a high percentage of patients. Due to the high prevalence of the administration of this drug, even a small percentage of errors in prescription can be significant and have important implications. The aim of the present study was to determine the frequency of supratherapeutic dosing of acetaminophen among hospitalized adult patients and its association with clinical outcomes. Methods and Materials: We conducted a retrospective, cross sectional study of all hospitalized adult patients in a teaching hospital affiliated to Mashhad University of Medical Sciences, Mashhad, Iran. Results: During the three-month study period, 4,781 (24.83%) out of 19,252 hospitalized cases received acetaminophen. Of those who received acetaminophen, 264 (5.5%) cases received a supratherapeutic dose at least once. Of 611 incidences of supratherapeutic dosing, 99.1% occurred in surgical wards and surgical intensive care units (ICUs), and 98.8% was associated with receiving parenteral formulations of acetaminophen. Multivariate analysis indicated supratherapeutic dosing of acetaminophen was significantly associated with multiple factors including female gender, older age, and longer length of hospital stays. Conclusion: All things considered, the percentage of hospitalized adult patients who received any dose of acetaminophen at our center was considerably less than other countries. Despite this, the frequency of instances of supratherapeutic dosing of this medication was significant (i.e. 17.6 days per 1,000 patient-days). Considering recent reports concerning the risk of hepatotoxicity associated with the repeated use of supratherapeutic doses of acetaminophen, continuous monitoring of acetaminophen utilization in order to prevent these instances is needed. Furthermore, based on the low percentage of patients who receive acetaminophen at our center, conducting research to study the pattern of prescription of analgesics and antipyretics in our center and its association with clinical outcome is logical.\",\"PeriodicalId\":14582,\"journal\":{\"name\":\"Iranian Journal of Pharmaceutical Sciences\",\"volume\":\"15 1\",\"pages\":\"83-90\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Iranian Journal of Pharmaceutical Sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.22034/IJPS.2018.85076.1429\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Pharmacology, Toxicology and Pharmaceutics\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Iranian Journal of Pharmaceutical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22034/IJPS.2018.85076.1429","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
Supratherapeutic Dosing of Acetaminophen in Iranian Hospitalized Adult Patients
Background: Acetaminophen is the most commonly used analgesic and fever-lowering agent that is prescribed in a high percentage of patients. Due to the high prevalence of the administration of this drug, even a small percentage of errors in prescription can be significant and have important implications. The aim of the present study was to determine the frequency of supratherapeutic dosing of acetaminophen among hospitalized adult patients and its association with clinical outcomes. Methods and Materials: We conducted a retrospective, cross sectional study of all hospitalized adult patients in a teaching hospital affiliated to Mashhad University of Medical Sciences, Mashhad, Iran. Results: During the three-month study period, 4,781 (24.83%) out of 19,252 hospitalized cases received acetaminophen. Of those who received acetaminophen, 264 (5.5%) cases received a supratherapeutic dose at least once. Of 611 incidences of supratherapeutic dosing, 99.1% occurred in surgical wards and surgical intensive care units (ICUs), and 98.8% was associated with receiving parenteral formulations of acetaminophen. Multivariate analysis indicated supratherapeutic dosing of acetaminophen was significantly associated with multiple factors including female gender, older age, and longer length of hospital stays. Conclusion: All things considered, the percentage of hospitalized adult patients who received any dose of acetaminophen at our center was considerably less than other countries. Despite this, the frequency of instances of supratherapeutic dosing of this medication was significant (i.e. 17.6 days per 1,000 patient-days). Considering recent reports concerning the risk of hepatotoxicity associated with the repeated use of supratherapeutic doses of acetaminophen, continuous monitoring of acetaminophen utilization in order to prevent these instances is needed. Furthermore, based on the low percentage of patients who receive acetaminophen at our center, conducting research to study the pattern of prescription of analgesics and antipyretics in our center and its association with clinical outcome is logical.
期刊介绍:
Iranian Journal of Pharmaceutical Sciences (IJPS) is an open access, internationally peer-reviewed journal that seeks to publish research articles in different pharmaceutical sciences subdivisions: pharmacology and toxicology, nanotechnology, pharmaceutics, natural products, biotechnology, pharmaceutical chemistry, clinical pharmacy and other pharmacy related topics. Each issue of the journal contents 16 outstanding research articles in area of pharmaceutical sciences plus an editorial written by the IJPS editors on one of the most up to date advances topics in pharmacy. All articles published by IJPS would be permanently accessible online freely without any subscription charges. Authors of the published articles have granted the right to use and disseminate their article to third parties.